Zosano Pharma Corp. (ZSAN) has decided to discontinue development of its Daily ZP-PTH treatment for severe osteoporosis and has terminated the exclusive agreement with Eli Lilly and Co. (LLY) that was signed last December.
Forex – financial instrument.Forex news
Zosano Pharma Corp. (ZSAN) has decided to discontinue development of its Daily ZP-PTH treatment for severe osteoporosis and has terminated the exclusive agreement with Eli Lilly and Co. (LLY) that was signed last December.